Accession Number: | 0001127602-21-009099 |
Date: | 2021-03-01 |
Issuer: | APELLIS PHARMACEUTICALS, INC. (APLS) |
Original Submission Date: |
PERRY NICOLE D
C/O APELLIS PHARMACEUTICALS, INC.
100 FIFTH AVENUE, 3RD FLOOR
WALTHAM, MA 02451
Title of Security | Transaction Date | 2a. Deemed Execution Date | Transaction Code | Shares | Acquired or Disposed | Price per share | 5. Amount of Securities Beneficially Owned Following Reported Transaction | 6. Ownership Form Direct or Indirect | Nature of Indirect Ownership |
---|---|---|---|---|---|---|---|---|---|
COMMON STOCK | 2021-03-01 | M | 2,000 | a | $3.76 | 4,347 | direct | ||
COMMON STOCK | 2021-03-01 | S | 2,000 | d | $50.00 | 2,347 | direct |
Title of Derivative Security | Conversion or Exercise Price of Derivative Security | Transaction Date | Deemed Execution Date | Transaction Code | Number of Derivative Securities Acquired (A) or Disposed of (D) | Date Exercisable | Expiration Date | Title and Amount of Securities Underlying Derivative Security | Price of Derivative Security | Number of derivative Securities Beneficially Owned Following Reported Transaction(s) | Ownership Form: Direct (D) or Indirect (I) | Nature of Indirect Beneficial Ownership |
---|---|---|---|---|---|---|---|---|---|---|---|---|
STOCK OPTION (RIGHT TO BUY) | 3.76 | 2021-03-01 | deemed execution date | M | 2,000 (d) | 2025-07-31 | common stock 2,000 | $3.76 | 11,161 | direct |
ID | footnote |
---|---|
f1 | this is a scheduled exercise from a 10b5-1 trading plan. |
f2 | this option was granted on july 31, 2015 and is fully vested. |